Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial-Reference-Cited by-同舟云学术

Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial

Published:2016-06-23 Issue:2 Volume:5 Page:e110
ISSN:1929-0748
Container-title:JMIR Research Protocols
language:en
Short-container-title:JMIR Res Protoc

Author:

Anyanwu Juliana N^ORCID,Williams Olatundun^ORCID,Sautter Casey L^ORCID,Kasirye Phillip^ORCID,Hume Heather^ORCID,Opoka Robert O^ORCID,Latham Teresa^ORCID,Ndugwa Christopher^ORCID,Ware Russell E^ORCID,John Chandy C^ORCID

Publisher

JMIR Publications Inc.

Subject

General Medicine

Reference58 articles.

1. Sickle-cell disease

2. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates

3. Sickle Cell Disease in Africa

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Models of care for sickle cell disease in low-income and lower-middle-income countries: a scoping review;The Lancet Haematology;2024-04

2. Characterization of a cohort of Angolan children with sickle cell anemia treated with hydroxyurea;Blood Cells, Molecules, and Diseases;2024-03

3. Angiopoietin-2 is associated with sickle cell complications, including stroke risk, and decreases with hydroxyurea therapy;Blood Vessels, Thrombosis & Hemostasis;2024-03

4. Prevalence of Use of Herbal Medicines for the Treatment of Sickle Cell Disease in Africa: a Systematic Review and Meta-analysis;Journal of Herbal Medicine;2023-12

5. Hydroxyurea for children with sickle cell disease in sub‐Saharan Africa: A summary of the evidence, opportunities, and challenges;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-03-26